Summary & Overview
HCPCS G6051: Flurazepam, Outpatient Pharmacy Dispensing
HCPCS Level II code G6051 denotes flurazepam, an oral benzodiazepine prescribed for short-term treatment of insomnia. Nationally, accurate identification of this HCPCS Level II code is important for pharmacy billing, medication management, and insurer coverage determinations for sedative-hypnotic therapies. Payers commonly involved in reimbursement and coverage include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare.
Readers will find a concise overview of the clinical role of flurazepam and the billing context for G6051, plus operational benchmarks and policy considerations relevant to payers and providers. The publication outlines typical sites of service and service line implications for dispensing this medication in outpatient pharmacy and clinic settings. When available, benchmarks cover utilization patterns, billing frequency, and payer coverage nuances. Policy updates emphasize coding accuracy, documentation expectations, and payer-specific coverage policies. This summary is designed for billing managers, pharmacists, and revenue cycle professionals seeking a national perspective on billing and coverage for G6051.
Billing Code Overview
HCPCS Level II code G6051 represents Flurazepam, a benzodiazepine-class medication used for short-term management of insomnia and related sleep disorders. The service type associated with this code is dispensing or provision of the medication. The typical site of service for G6051 is outpatient pharmacy or clinic-based medication administration where prescription medications are dispensed to patients.
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult experiencing primary or secondary insomnia who has been evaluated in an outpatient sleep medicine or psychiatric clinic. The patient reports difficulty initiating and/or maintaining sleep for several weeks to months despite sleep hygiene measures. A clinician (psychiatrist, sleep medicine specialist, or primary care physician) documents the insomnia diagnosis, assesses contraindications (e.g., severe respiratory depression, untreated sleep apnea), reviews current medications, and determines flurazepam is an appropriate hypnotic agent. The clinician prescribes flurazepam with dosing instructions, documents informed consent regarding sedation, next-day drowsiness, fall risk, and potential dependence, and provides counseling on safe use. Typical workflow steps include history and medication review, physical exam focused on cardiopulmonary and neurologic status, counseling and informed consent, prescription generation (paper or e-prescribe), and follow-up scheduling to monitor efficacy and adverse effects. Pharmacy dispensing occurs in an outpatient retail or hospital outpatient pharmacy. Typical site of service is outpatient clinic or ambulatory care with medication dispensed in a retail pharmacy or hospital outpatient pharmacy.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
TC | Technical component | Use when billing only the technical component of a service or supply; for a drug code, rarely applicable but used when separating technical aspects such as dispensing fees if payer allows. |